Inhibition of progesterone-induced VEGF production in human breast cancer cells by the pure antiestrogen ICI 182,780

Cancer Letters

Volumn 181, Issue 1, 2002, Pages 47-53

  Hyder, Salman M ^a   Stancel, George M ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Antiestrogen; Antiprogestin; Estrogen receptor; Progesterone receptor; Vascular endothelial growth factor

Indexed keywords

ANTIESTROGEN; FULVESTRANT; MESSENGER RNA; PROGESTERONE; PROGESTERONE RECEPTOR; VASCULOTROPIN;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL LEVEL; CELL SUBPOPULATION; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFECT; DRUG SCREENING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN SYNTHESIS INHIBITION; RECEPTOR BINDING; RECEPTOR BLOCKING;

BREAST NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; ESTRADIOL; ESTROGEN RECEPTOR MODULATORS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; RECEPTORS, PROGESTERONE; RNA, MESSENGER; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037043127     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00048-4     Document Type: Article

References (22)

1. Tamoxifen, raloxifene, and the prevention of breast cancer
2. Tamoxifen for prevention of breast cancer: Report of the national surgical adjuvant breast and bowel project P-1 study. Tamoxifen: The herald of a new era of preventive therapeutics
3. American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: Tamoxifen and raloxifene
4. Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer
5. ICI 182,780 (Faslodex)
6. The pure antiestrogen ICI 182,780 inhibits progestin-induced transcription
7. Angiogenesis in cancer, vascular, rheumatoid and other disease
8. Angiogenesis and breast cancer
9. Regulation of VEGF in the reproductive tract by sex-steroid hormones
10. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma
11. Prognostic value of vascular endothelial growth factor in breast cancer
12. Progestin regulation of vascular endothelial growth factor in human breast cancer cells
13. Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells
14. Isolation of biologically active ribonucleic acids from sources enriched in ribonucleases
15. Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen
16. Synthetic estrogen 17alpha-ethinyl estradiol induces pattern of uterine gene expression similar to endogenous estrogen 17beta-estradiol
17. High-performance hydrophobic interaction chromatography of estrogen receptors and in the presence and absence of sodium molybdate
18. Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines
19. Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer
20. Treatment of breast cancer with different antiprogestins: Preclinical and clinical studies
21. Antiprogestins, a new form of endocrine therapy for human breast cancer
22. Vascular endothelial growth factor (vegf) in human breast cancer - Correlation with disease-free survival